G
Gleamer
Biotech & Life Sciences · Saint-Mandé, France · Founded 2017
Providing imaging users a suite of Artificial Intelligence solutions covering a wide range of clinical applications MoreLess
GLEAMER is a French company founded in 2017 by Christian Allouche and Alexis Ducarouge. The company develops and markets artificial intelligence-powered software for medical imaging, specifically for radiology.
The company's main product is BoneView, a software that uses AI to detect fractures in X-ray images. BoneView is designed to be used by radiologists and emergency physicians to help them make more accurate and efficient diagnoses. The software is CE-marked and has received FDA clearance in the United States.
In addition to BoneView, GLEAMER also offers ChestView, a software that helps detect pulmonary pathologies in chest X-rays.
GLEAMER's business model is based on a subscription fee for its software. The company targets hospitals, clinics, and teleradiology companies as its primary customers.
Keywords: medical imaging, radiology, artificial intelligence, fracture detection, diagnostic aid, CE mark, FDA clearance, BoneView, ChestView, teleradiology.
Talent graph
Gleamer's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Gleamer has talent and traffic
team presence
Market sentiment
What the market is saying about Gleamer
An AI-synthesized read of the highest-engagement posts about Gleamer on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Gleamer on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.